ÂÜÀòÂÒÂ×

Lorraine H. Keller, Ph.D. Dr. Keller has more than 30 years of technical and project management experience in the life sciences industry. She has held executive-level positions in product development, R&D strategy, technology assessment, competitive intelligence, licensing, intellectual property protection, and grant preparation. She co-founded and held senior executive positions in four life sciences companies engaged in disciplines ranging from gene therapy to medical device design and manufacture. At Immunotope, a human health immunotherapy company, she was a member of the team developing T cell epitope-based vaccines for cancer and infectious diseases and identification of autoantibodies for cancer diagnostics. As CSO of MBF Therapeutics, Dr. Keller is responsible for the day-to-day management of research and development for cancer and infectious disease vaccines for companion animals and livestock. Her responsibilities include project identification and strategic planning, new technology assessment, and acquisition to build MBFT’s R&D capabilities and its patent estate. She oversees the technical and scientific aspects of manufacturing and regulatory affairs for the company’s products. She has consulted extensively for early-stage life science companies in the fields of immunotherapy, diagnostics, and small molecule drugs.